CTL RSV RSV. CTL T cell receptor TCR HLA class HLA B52 B7. clonal expansion CTL CTL clone B52 B7. T cytotoxic T lymphocyte MHC CTL B52 B7



Similar documents
The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Autoimmunity and immunemediated. FOCiS. Lecture outline

2) Macrophages function to engulf and present antigen to other immune cells.

Immunology and immunotherapy in allergic disease

Basics of Immunology

Name (print) Name (signature) Period. (Total 30 points)

Chapter 43: The Immune System

Microbiology AN INTRODUCTION EIGHTH EDITION

Cytotoxic T Lymphocytes (CTLs) and NK Cells. Effector T cells. After activation, naïve T cells differentiate into effector and memory T cells

T Cell Maturation,Activation and Differentiation

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

TABLE OF CONTENT. Page ACKNOWLEDGEMENTS. iii ENGLISH ABSTRACT THAI ABSTRACT. vii LIST OF TABLES LIST OF FIGURES. xvi ABBREVIATIONS.

Pulling the Plug on Cancer Cell Communication. Stephen M. Ansell, MD, PhD Mayo Clinic

B Cells and Antibodies

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

The Link Between Viruses and Asthma Catherine Kier, M.D.

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

Understanding the immune response to bacterial infections

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

Drug Development Services

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

Rheumatoid arthritis: an overview. Christine Pham MD

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

Final Review. Aptamers. Making Aptamers: SELEX 6/3/2011. sirna and mirna. Central Dogma. RNAi: A translation regulation mechanism.

Core Topic 2. The immune system and how vaccines work

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES

A white paper for consideration by the NIAID Microbial Sequencing Program

B Cell Generation, Activation & Differentiation. B cell maturation

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System

Wheezing in Children. Prof RJ Green Department of Paediatrics

Cytotoxic T lymphocytes and natural killer cells

Dendritic Cells: A Basic Review *last updated May 2003

Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center

Why use passive immunity?

The Immune System: A Tutorial

Custom Antibody Services

Immunology Ambassador Guide (updated 2014)

Supplemental Material CBE Life Sciences Education. Su et al.

Corporate Medical Policy

Identification of Tick-Borne Encephalitis Virus CD4+ and CD8+ T-Cell Epitopes in Vaccinated or Naturally Infected Humans

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy

The Body s Defenses CHAPTER 24

02/08/ Background. Outline

Reconsideration Code Reconsideration Code Description Nuclear Matrix Protein 22 (NMP22), qualitative

1 DNA Vaccines An Overview

Mechanical barriers are a crucial first line of defence. It would be impossible to provide an exhaustive list. Two examples are:

Cytomegalovirus (HHV5/CMV) Roseolovirus (HHV6 & 7)

Chimeric Antigen Receptor T Cell Therapy

A Genetic Analysis of Rheumatoid Arthritis

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology

TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS.

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

Immunity and how vaccines work

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

OKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~

In vitro co-culture model of the inflamed intestinal mucosa

HLA Class I-Restricted Cytotoxic T-Cell Epitopes of the Respiratory Syncytial Virus Fusion Protein

Assays to evaluate cell-mediated immunity. Guus Rimmelzwaan Department of Virology Erasmus Medical Center Rotterdam The Netherlands

FIGHTING AIDS AT THE GATE

Activation and effector functions of HMI

Focus on Preventing Disease. keeping an eye on a healthy bottom line. Cattle Industry

Antibody Function & Structure

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

The Four Pillars of Cancer Therapy

Oncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March Antti Vuolanto, COO and co-founder

PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands

B cell activation and Humoral Immunity

H. Richard Alexander, Jr., M.D. Department of Surgery and The Greenebaum Cancer Center University of Maryland School of Medicine Baltimore, Md

Figure 14.2 Overview of Innate and Adaptive Immunity

BIOM Firestein, Winter Rheumatoid arthritis. Page 1

Hypersensitivity. TYPE I Hypersensitivity Classic allergy. Allergens. Characteristics of allergens. Allergens. Mediated by IgE attached to Mast cells.

Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University

About Our Products. Blood Products. Purified Infectious/Inactivated Agents. Native & Recombinant Viral Proteins. DNA Controls and Primers for PCR

ELISA BIO 110 Lab 1. Immunity and Disease

BVIG/SBMI Meeting Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium

Presenter Disclosure: Renier J. Brentjens, MD, PhD. Nothing to disclose

PEPVAC: A web server for multi-epitope vaccine development based on the prediction of supertypic

Environmental, genetic and immunological determinants of Rheumatoid Arthritis


VPM 152. INFLAMMATION: Chemical Mediators

Fattori implicati nel rimodellamento tissutale epatico

Viruses. Viral components: Capsid. Chapter 10: Viruses. Viral components: Nucleic Acid. Viral components: Envelope

Direct Testing Systems and Serology

DEPARTMENT OF IMMUNOLOGY Chair of Histology and Immunology Medical University of Gdańsk

Liver Disease and Therapy of Hepatitis B Virus Infections

Welcome to Mini Med School at the Child & Family Research Institute

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

Autoimmunity. Autoimmunity. Genetic Contributions to Autoimmunity. Targets of Autoimmunity

How do plasma cells survive

Parvovirus B19 Infection in Pregnancy

Gestione della dermatite atopica

Influenza (Flu) Influenza is a viral infection that may affect both the upper and lower respiratory tracts. There are three types of flu virus:

What is HIV? What is AIDS? The HIV pandemic HIV transmission Window period Stages of HIV infection

Effector Mechanisms of Humoral Immunity

Identification of T-cell epitopes of SARS-coronavirus for development of peptide-based vaccines and cellular immunity assessment methods

Back to Index. 1. Immunological Tolerance and Autoimmunity 1. Tolerance. 2. Mechanisms of tolerance to self-antigens

The Immune System. 2 Types of Defense Mechanisms. Lines of Defense. Line of Defense. Lines of Defense

Transcription:

2014 Vol. 26No. 167 45 RS 45 30 RS RSV RSV 1978 T cytotoxic T lymphocyte CTL MHCHLA ZinkernagelDoherty 1 CTL MHC CTL 23 1 2 HLA B52 B7 2 3 CTL T cell receptortcr HLAclass 3 CTL HLA B52B7 TCR CTL clonal expansion CTL CTL clone B52B7 B52B7 2 1984 1 1986 4 NY Ogra 0608543 1 16

68 2014 CTL 1 CTL 23 RSV 20 3 RSV RSV 1 RSV RSV A B AB 2 CTL HLA HLA B52B7

2014 Vol. 26No. 169 3 RSV HEp2 4 46 PCR RSV G RSV 10 23 79 G 60 B 2 12 10 4RSV AB 19801996 23

70 2014 5RSV RSV IgAIgG IgA IgG 2 IgA 0.1 mgml RSV 1 RSV RSV RSV RSV RSV nasopharyngeal secretionnps IgA IgG IgG 12 5 RSV 6 11 2 RSV RSV 7 RSV 2 12 RSV IL6TNF 8 13 in vitro RSV

2014 Vol. 26No. 171 6RSV RSV IgAIgG RSV IgAIgG IgA 0.1 mgml mrna 2 10 14,15 in vitro RSV NO 16,17 9 RSV RSV TLR3 TLR4 2 RNARSV F LPS HDM house dust miteil 8 RANTES l l 7RSV 2 HE 8RSV IL6 TNF IL6TNF IgA 0.1 mgml 1821 LT

72 2014 9RSV 10RSV 10RSV RSV TLR4 SNPs 22 23 RSV 3 RS RSV 11 RSV 2 in vivo in vitro RSV htert in vivo

2014 Vol. 26No. 173 11 RSV RSV RSV 24 RSV RSV RSV occludinclaudin 4 RSV RSV TGFPKCHIF1NF B 12 24,25 26,27 RS RSV reactive airway diseaserad NTT 20032010 RSV 1 1 RSV RSV 28 RSV MMPmatrix metalloproteinase MMP10 29 MMP10 RSV RAD RS 20 RSV 2

74 2014 12RSV RSV TGFPKCHIF1NFB RSV RSV RSV 1990. 1 RSV 2001. 7 RSV 2004.11 RSV 2011.11 RSV RSV 2003.11 RSV 5 1998. 6 RSVF MAbFDA 2002. 1 CLD 2005.10 CHD 2013. 8 RSV RSV ELISA RSV 1990 5 13 3032 RSV MedImmune 1998 RSV complementarity determining regioncdr IgG RSV AB RSV RSV

2014 Vol. 26No. 175 13RSV 33 RSV RSV 5 10 23 33 serendipity 2 1Zinkernagel RM, et alrestriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248701702, 1974 2Tsutsumi H, et altcellmediated cytotoxic response to mumps virus in humans. Infect Immun 30129134, 1980 3Chiba Y, et alhuman leukocyte antigenlinked genetic controls for T cellmediated cytotoxic response to mumps virus in humans. Infect Immun 35600604, 1982 4Tsutsumi H, et almonoclonal antibodies to the large glycoproteins of respiratory syncytial virus possible evidence for several functional antigenic sites. J Gen Virol 6821612167, 1987 5Tsutsumi H, et aloccurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987. J Clin Microbiol 2611711174, 1988 6Tsutsumi H, et alantigenic variation of human RSV strains isolated in Japan. J Med Virol 27 124130, 1989 7Seki K, et algenetic variability of respiratory syncytial virus subgroup a strain in 15 successive epidemics in one city. J Med Virol 64374380, 2001 8Kamasaki H, et algenetic variability of respiratory syncytial virus subgroup B strain isolated during the last 20 years from the same region in Japanexistence of timedependent linear genetic drifts. Arch Virol 146457466, 2001 9Kuroiwa Y, et ala phylogenetic study of human respiratory syncytial viruses group A and B strains isolated in two cities in Japan from 1980 2002. J Med Virol 76241247, 2005 10Nagai K, et alnosocomial outbreak of respiratory syncytial virus subgroup B variants with the 60 nucleotidesduplicated G protein gene. J Med Virol 74161165, 2004 11Tsutsumi H, et aldifferent kinetics of antibody responses between IgA and IgG classes in nasopharyngeal secretion in infants and children during

76 2014 primary respiratory syncytial virus infection. Acta Pediatr Jpn 37464468, 1995 12 respiratory syncytial virus 8620762082 1982 13Matsuda K, et aldevelopment of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin Diagn Lab Immunol 2322324, 1995 14Matsuda K, et alcharacteristics of IL6 and TNFalpha production by respiratory syncytial virusinfected macrophages in the neonate. J Med Virol 48199203, 1996 15Tsutsumi H, et alrespiratory syncytial virus induced cytokine production by neonatal macrophages. Clin Exp Immunol 106442446, 1996 16Takeuchi R, et alrespiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin1betaconverting enzyme gene expression but does not cause apoptosis. J Virol 724498 4502, 1998 17Tsutsumi H, et alrespiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression. J Leukoc Biol 6699104, 1999 18Groskreutz DJ, et alrespiratory syncytial virus induces TLR3 protein and protein kinase R, Leading to increased doublestranded RNA responsiveness in airway epithelial cells. J Immunol 176 17331740, 2006 19KurtJones EA, et alpattern recongnition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nature Immunol 1398401, 2000 20Monick MM, et alrespiratory syncytial virus upregulates TLR4 and sensitizes airway epithelial cells to endotoxin. J Birol Chem 27853035 53044, 2003 21Hammad H, et alhouse dust mite allergen induces asthma via Tolllike receptor 4 triggering of airway structural cells. Nature Med 15410 416, 2009 22Tal G, et alassociation between common Toll like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 1892057 2063, 2004 23Fernandes RM, Bialy LM, Vandermeer B, et al Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev CD004878, 2010 24Masaki T, et ala NFB signaling pathway via protein kinase C regulates replication of respiratory syncytial virus in polarized normal human nasal epithelial cells. Mol Biol Cell 222144 2156, 2011 25Tsutsumi H, et alrespiratory syncytial virus infection and the tight junctions of nasal epithelial cells. Adv Otorhinolaryngol 72153156, 2011 26Obata K, et alcurcumin prevents replication of respiratory syncytial virus and the epithelial responses to it in human nasal epithelial cells. PLoS One 188e70225, 2013 27Fuchimoto J, et alhumulone suppresses replication of respiratory syncytial virus and release of IL8 and RANTES in normal human nasal epithelial cells. Med Mol Morphol 46203209, 2013 281 RS 557984, 2014 29Hirakawa S, et almarked induction of matrix metalloproteinase10 by respiratory syncytial virus infection in human nasal epithelial cells. J Med Virol 8521412150, 2013 30RSV respiratory syncytial virusrsv 95949954 1991 31Directigen RSV respiratory syncytial virus 472612631999 32Kuroiwa Y, et alcomparison of an immunochromatography test with multiplex reverse transcriptionpcr for rapid diagnosis of respiratory syncytial virus infections. J Clin Microbiol 424812 4814, 2004 33 RS 112106810752008